This site is intended for healthcare professionals only
LoginRegister

Nephrology Dialogues

Canagliflozin reduces hyperkalemia risk in patients with diabetes and CKD: CREDENCE trial

Canagliflozin reduces hyperkalemia risk in patients with diabetes and CKD: CREDENCE trial

Australia: Hyperkalemia is common in people with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), and it is associated with the...
View All

Latest News and Guidelines

ICU delirium frequently linked with acute renal damage, finds a new study

ICU delirium frequently linked with acute renal damage, finds a new study

Eplerenone reduces urinary Albumin creatinine ratio in diabetics at high risk of CVD: Study

Eplerenone reduces urinary Albumin creatinine ratio in diabetics at high risk of CVD: Study

Exposure to pesticide Malathion linked to chronic kidney disease, finds study

Exposure to pesticide Malathion linked to chronic kidney disease, finds study

Dietary potassium not tied to hyperkalemia in hemodialysis patients: DIET-HD study

Dietary potassium not tied to hyperkalemia in hemodialysis patients: DIET-HD study

Patients with kidney transplants more vulnerable to Nocardia infection, finds study

Patients with kidney transplants more vulnerable to Nocardia infection, finds study

Standing scrotal Ultrasound effective way for diagnosing Varicoceles, finds study

Standing scrotal Ultrasound effective way for diagnosing Varicoceles, finds study

View All
X